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Case Description
A 30-year-old woman presented to hospital in Dhaka,
Bangladesh, with 10 hours of sudden onset of voluminous diarrhea
and vomiting. Since onset, the patient had experienced seven
episodes of diarrhea and three of vomiting, and ingested
approximately 2 liters of oral rehydration solution at home. She
lived in an informal settlement area of Dhaka with two young
children and a husband who was a day-laborer. The family would
often drink unboiled tap water stored in open large containers, and
shared a toilet with approximately 20 other families. The patient’s
past medical history was unremarkable. On admission, no family
member was suffering from severe diarrhea. On examination, the
patient was lethargic and thirsty, and had sunken eyes, dry buccal
mucosa, reduced skin turgor, deep and rapid breathing, and a
feeble pulse (Figure 1). She had not urinated since onset of illness.
Other systemic examination findings were normal. The patient’s
stool (Figure 2) had a fishy odor.
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Figure 1. The patient on presentation.
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Cholera with severe dehydration leading to hypovolemic shock.
Clinical Course
Upon arrival, the patient was categorized as severely dehydrat-
ed (.10% total body volume depleted), and immediately treated
with intravenous infusion of cholera saline solution (Na
+133,K
+13,
Cl
298, and acetate
248) at a rapid rate of 100 ml/kg over the first
3 hours (with an accelerated rate of 30 ml/kg over the first 30
minutes). The progress of rehydration therapy was assessed hourly.
Due to lethargy, the patient was initially unable to consume
appreciable amounts of oral liquid until approximately 3 hours after
initiation of intravenous fluids, at which time the patient had received
approximately 4 liters of intravenous fluid. As diarrhea continued,
oral intake was continuously encouraged. Within 8 hours of arrival,
the patient was alert and oriented with good skin turgor, moist mucus
membranes, and a strong pulse. The patient began to void urine and
w a sa b l et oe a tb r e a ds o a k e di nac u po fm i l k ,a n db a n a n a( F i g u r e3 ) .
The patient continued to drink 1 liter of oral rehydration solution
(ORS) per hour to maintain fluid status while diarrhea continued.
Darkfield microscopy disclosed ‘‘shooting star’’ movement. The
patient was observed overnight, and then discharged and sent with
home with ORS. Upon admission, the patient was treated with a
single 1-gm oral dose of azithromycin.
Discussion
This impoverished afebrile adult patient in Bangladesh had
sudden onset of vomiting and voluminous rice-watery non-bloody
diarrhea with a fishy smell, and presented with severe dehydration
within a few hours of disease onset. Following rehydration, her
clinical status quickly improved. All of these clinical features are
compatible with cholera.
Diarrhea may be classified as watery (secretory) or dysenteric.
Dysenteric diarrhea is usually associated with fever, macroscopic
or microscopic presence of red and white blood cells in stool, and
frequent passage of small volume mucoid stools. Dysentery is
usually caused by enteropathogens that invade the intestinal
epithelium such as Shigella, Salmonella, Yersinia, Campylobacter, and
Entamoeba histolytica. Watery diarrhea is usually associated with
non-invasive enteropathogens, is not usually associated with fever
or blood in stool, and may be large volume. Severe watery
diarrhea in a young child may be due to rotavirus (especially in the
first one to two years of life), caliciviruses (including Norwalk virus
and other noroviridae), enterotoxigenic E. coli (ETEC), and
cholera. Sudden onset of a severe dehydrating diarrhea in
individuals over the age of five should be highly suspicious for
cholera, especially if more than one individual is affected in a
resource-poor area. Diagnosis of Vibrio cholerae infection may be
confirmed by seeing classic ‘‘shooting star’’ movement of
organisms when looking at a cholera stool under a dark field
microscope. A dipstick assay for rapid diagnosis use in resource-
limited areas is available [1], and microbiological culture of stool
or a rectal swab on selective media confirms the diagnosis,
permitting typing and susceptibility testing.
Of the approximately 200 serogroups of V. cholerae, only
serogroups O1 and O139 are associated with epidemic outbreaks
of cholera. The world is currently experiencing its 7th cholera
pandemic (caused by V. cholerae O1 El Tor). The vast majority of
cholera cases are not reported to the World Health Organization
(WHO), but it is estimated that at least 5–7 million individuals
develop clinical cholera each year, resulting in over 100,000
deaths. V. cholerae is endemic in over 50 countries, and the global
burden of disease is heaviest in South and Southeast Asia and sub-
Saharan Africa. There have been recent epidemic outbreaks in
Haiti, West Africa, and Zimbabwe. V. cholerae persists in the
environment, and is associated with brackish estuarine water,
especially in areas where fresh and salt water intermix. Humans
become infected when they ingest water (or less likely, food)
contaminated with V. cholerae, and the organisms becomes hyper-
infectious following passage through the human intestine,
facilitating explosive outbreaks and epidemics among immuno-
logically susceptible populations [2].
Cholera is a disease of poverty, and is associated with war,
displacement, an inability to obtain safe water, and an absence of
proper sanitation facilities. Outbreaks have been associated with
heavy rains and flooding [3]. In light of predicted regional
increases in severe weather events, rising sea levels, and increasing
flooding associated with global warming, as well as the ongoing
urbanization of the world’s population and growth of mega-cities
lacking adequate infrastructure, the global burden of cholera may
well increase over the next few decades.
Following ingestion, V. cholerae express cholera toxin (CT) within
the intestinal lumen, resulting in increased cAMP levels in
intestinal epithelial cells and pumping of Cl
2 (and therefore Na
+
and H20) into the intestinal lumen and secretory diarrhea. Total
flushing of the intestinal tract leads to ‘‘rice water’’ stool with a
fishy odor. Although the classic clinical manifestation of cholera is
a severe dehydrating diarrhea that can rapidly kill (cholera gravis),
Figure 2. The patient’s stool.
doi:10.1371/journal.pntd.0000898.g002
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asymptomatic colonization to diarrhea of varying severity.
The treatment of individuals with cholera is predominantly
based on fluid resuscitation and management. Individuals who die
of cholera die of dehydration or complications of hypovolemic
shock. Individuals with dehydrating diarrhea should be promptly
assessed for level of dehydration (Box 1). Based on the level of
dehydration and age or weight, individuals should be rapidly
rehydrated to eu-volemia, and then adequate hydration main-
tained to replace ongoing fluid losses (Table 1). ORS, also called
oral rehydration therapy or treatment (ORT), takes advantage of
the fact that despite the action of CT, intestinal epithelial cells can
still pump in electrolytes and water when sodium and glucose are
presented at the same time (using a different pump than that
affected by CT). Individuals who are unconscious or unable to
ingest ORS by mouth can be treated either by passing ORS fluid
down an inserted nasogastric tube, or by repleting fluids and
electrolytes intravenously. ORS may be made using pre-packaged
sachets containing salts and sugar and adding safe water, or at
home by adding half a teaspoon of table salt and 4 tablespoons of
table sugar to a liter of safe water, and encouraging potassium
intake using bananas or green coconut water.
Following fluid management, the administration of antibiotics
to individuals with cholera is only of secondary importance. The
WHO recommends administration of antibiotics to cholera
patients with severe dehydration only. Antibiotic administration
is associated with a decreased volume of diarrhea, so in resource-
limited settings antibiotic use will assist in conserving scarce
resources, and antibiotic administration decreases the likelihood of
secondary spread from a cholera patient to contacts. Unfortu-
nately, V. cholerae O1 are becoming increasingly resistant to
antimicrobial agents [4,5]. Choice of an appropriate antibiotic
should therefore consider regional susceptibility patterns. If
regional strains are susceptible, young children and women of
child-bearing age may be treated with erythromycin or azithro-
mycin. Doxycycline and fluoroquinolones may be used to treat
other individuals and/or based on susceptibility patterns.
Figure 3. The patient 8 hours after starting rehydration therapy.
doi:10.1371/journal.pntd.0000898.g003
Box 1. Assessing the Level of Dehydration
1. No dehydration, but diarrhea
N Corresponds to ,5% loss of total body weight
2. Some or moderate dehydration
Patient thirsty, dry mouth/tongue, no tears, sunken eyes,
skin pinch slow to retract
N Corresponds to 5%–10% loss of total body weight
3. Severe dehydration
Patient unconscious, lethargic or floppy, weak pulse,
unable to drink
Corresponds to .10% loss of total body weight
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the most available vaccines globally are versions of an oral killed
whole cell vaccine with or without addition of the non-toxic B
subunit of CT [6,7]. Oral administration of whole cell killed
vaccines is associated with protective immunity that may be as
high as 60%–90% immediately after vaccination, but requires
more than one oral administration in immunologically naı ¨ve
individuals, and protection wanes rapidly, decreasing to baseline
within 6–36 months of vaccination.
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Table 1. Treatment (Based on Level of Dehydration).
No Dehydration, but Diarrhea:
ORS replacement after each stool:
N For children ,2 years of age, give J–1/2 cup (50–100 ml) ORS to maximum of 0.5 liters per day.
N For children 2–9 years of age, give 1/2–1 cup (100–200 ml) ORS to maximum of 1 liter per day.
N For individuals 10 years of age and older, give as much ORS as wanted up to a maximim of 2 liters per day.
N Reassess regularly, and follow stool and vomit output.
Some or Moderate Dehydration:
ORS replacement to be given within first 4 hours
Age Less than 4 months 4–11 months 12–23 months 2–4 years 5–14 years 15 years
Weight Less than 5 kg 5–,8k g 8 – ,11 kg 11–,16 kg 16–,30 kg 30 kg or more
ORS 200–400 ml 400–600 ml 600–800 ml 800–1200 ml 1200–2200 ml 2200–4000 ml
NReassess regularly, and follow stool and vomit output.
Severe Dehydration:
Administer intravenous fluid replacement with Ringer Lactate (or cholera saline) or, if not available, normal saline.
N 100 ml/kg in first 3-hour period (slow to first 6-hour period when treating children less than 12 months of age)
N Start rapidly (30 ml/kg within 30 min) and then slow down.
Total amount per day: 200 ml/kg during the first 24 hours
N Reassess regularly, and follow stool and vomit output.
N Continue intravenous therapy until the patient is awake and able to ingest ORS and pulse is no longer weak.
Continue normal feeding during treatment
Adapted from [8].
doi:10.1371/journal.pntd.0000898.t001
Key Learning Points
N Diarrhea may be classified as watery or dysenteric.
N Severe watery diarrhea in an individual over 5 years of age should prompt consideration of cholera.
N Cholera is a disease of poverty and displacement.
N Individuals with cholera can die of dehydrating diarrhea within 12–24 hours of onset.
N The treatment of all individuals with diarrhea, but especially and emergently true for patients with cholera, includes rapid
and simple assessment of the level of dehydration, followed by appropriate fluid replacement and management of
ongoing fluid losses.
N Cholera patients with severe dehydration may also be treated with an appropriate antimicrobial agent.
N Although optimal prevention of cholera includes provision of safe water and adequate sanitation, such goals may not be
feasible in the short or medium term for those most affected by cholera, suggesting that cholera vaccines may need to be
used more widely.
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